Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
27.05 USD | -0.26% | -3.43% | -32.99% |
Financials (USD)
Sales 2024 * | 361M | Sales 2025 * | 248M | Capitalization | 5.06B |
---|---|---|---|---|---|
Net income 2024 * | -450M | Net income 2025 * | -528M | EV / Sales 2024 * | 16.7 x |
Net Debt 2024 * | 968M | Net Debt 2025 * | 1.44B | EV / Sales 2025 * | 26.2 x |
P/E ratio 2024 * |
-9.93
x | P/E ratio 2025 * |
-9.21
x | Employees | 553 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 74.93% |
Latest transcript on BridgeBio Pharma, Inc.
1 day | -0.26% | ||
1 week | -3.43% | ||
Current month | -3.43% | ||
1 month | -2.66% | ||
3 months | -9.83% | ||
6 months | -19.52% | ||
Current year | -32.99% |
Managers | Title | Age | Since |
---|---|---|---|
Neil Kumar
FOU | Founder | 45 | 14-12-31 |
Charles Homcy
FOU | Founder | 75 | 14-12-31 |
Founder | 73 | 14-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
James Momtazee
BRD | Director/Board Member | 52 | 16-02-29 |
Founder | 73 | 14-12-31 | |
Fred Hassan
BRD | Director/Board Member | 78 | 21-08-16 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.35% | 2 M€ | -.--% | ||
0.12% | 7 M€ | -.--% | - | |
0.11% | 0 M€ | 0.00% | - | |
0.08% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 27.05 | -0.26% | 1,150,815 |
24-06-06 | 27.12 | -3.14% | 1,366,159 |
24-06-05 | 28 | +3.21% | 1,567,560 |
24-06-04 | 27.13 | -6.38% | 4,176,210 |
24-06-03 | 28.98 | +3.46% | 1,577,902 |
Delayed Quote Nasdaq, June 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.99% | 5.06B | |
+0.82% | 91.94B | |
-1.32% | 38.74B | |
-12.88% | 32.82B | |
+64.77% | 26.66B | |
-16.31% | 15.32B | |
-5.78% | 13.3B | |
-11.38% | 11.65B | |
+173.10% | 10.37B | |
-49.84% | 10.12B |
- Stock Market
- Equities
- BBIO Stock